Compare EDAP & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EDAP | LNSR |
|---|---|---|
| Founded | 1979 | 2004 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical Electronics |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.4M | 146.7M |
| IPO Year | 1998 | 2005 |
| Metric | EDAP | LNSR |
|---|---|---|
| Price | $3.72 | $11.69 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $8.50 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 59.0K | 34.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $53,494,000.00 |
| Revenue This Year | N/A | $19.55 |
| Revenue Next Year | $7.15 | $35.89 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.87 |
| 52 Week Low | $1.21 | $9.46 |
| 52 Week High | $5.05 | $17.31 |
| Indicator | EDAP | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 46.03 | 45.67 |
| Support Level | $3.64 | $11.15 |
| Resistance Level | $4.24 | $12.80 |
| Average True Range (ATR) | 0.38 | 0.32 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 43.23 | 51.11 |
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.